Prospective Registry of Young-Adult Patients Diagnosed With Pancreatic Cancer
Recruiting
- Conditions
- PDAC - Pancreatic Ductal Adenocarcinoma
- Registration Number
- NCT05845801
- Brief Summary
The objective of the present registry is the creation of a prospective registry collecting clinico-pathological and genomic data, along with survival outcomes, of individuals diagnosed with PDAC at or before the age of 55 years old. This registry is intended with the aim of using collected data for future clinical trials, both prospective and retrospective.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 3000
Inclusion Criteria
- Age ≤55 years old at the time of diagnosis of pancreatic cancer
- Age ≥ 18 years
- Written informed consent obtained.
Exclusion Criteria
- Any pancreatic neoplasm other than pancreatic cancer (e.g. cholangiocarcinoma, ampullary cancer,duodenal cancer, non-invasive mucinous cystic neoplasm, pancreatic intra-epithelial neoplasia 1 and 2, non-invasive intraductal papillary mucinous neoplasm, serous cystic neoplasm, pseudo papillary solid tumor, neuroendocrine tumor)
- Absence of informed consent.
- Age < 18 years or > 55 years old at the time of diagnosis of pancreatic cancer
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Register of young PDAC patients 30 years Prospective collection of epidemiological, clinical, and pathological data of patients diagnosed with early-onset pancreatic cancer (EO-PDAC) - namely, individuals who have received a diagnosis of pancreatic cancer before, or at, the age of 55 years old.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
AOUI Verona
🇮🇹Verona, Italy